ASX share Ideas
2 ETFs I’d buy right away in November 2022
Exchange-traded funds (ETFs) can be a very useful way for people to invest in the share market for the long-term.
November 8, 2022
Big money is not in the buying or selling, but in the waiting.
For my own portfolio, I like to find ASX shares that are growing their dividends. Growth is an essential part of the dividend equation for me. I want to see that the dividend increases are funded by growing earnings and/or growing underlying asset values. I also have a portion of my portfolio invested in an ETF that picks undervalued global businesses with strong competitive advantages.
For Rask Media, I have an interest in covering technology (and tech-related) businesses with a global growth story, as well as cyclical companies that are cheaply priced because they’re at a low point in the cycle, such as retailers and resource businesses which could benefit strongly in the medium-term.
Exchange-traded funds (ETFs) can be a very useful way for people to invest in the share market for the long-term.
The Medibank Private Limited (ASX:MPL) share price is under the spotlight today on the private health insurer’s latest cybersecurity update.
The Westpac Banking Corp (ASX:WBC) share price is under the spotlight today, the major bank just reported its FY22 result.
The Block Inc (ASX:SQ2) share price is up more 10% after revealing its quarterly update, which showed more gross profit growth.
The Magellan Financial Group Ltd (ASX:MFG) share price is under the spotlight as more funds left the building in October.
The A2 Milk Company Ltd (ASX:A2M) share price is in focus today after the business announced FDA approval in the US.
I think that some ASX dividend shares look like real opportunities right now, including Pinnacle Investment Management Group Ltd (ASX:PNI).
The Goodman Group (ASX:GMG) share price has dropped more than 2% after the large industrial property business announced its quarterly update.
The CSL Limited (ASX: CSL) share price is in focus today after the biotech giant made a mRNA vaccine announcement.
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
Here you go: A $50,000 per year passive income special report
Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.
Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.
Unsubscribe anytime. Read our Terms, Financial Services Guide, Privacy Policy. We’ll never sell your email address. Our company is Australian owned.